Are GLP-1 medications revealing deeper metabolic issues beyond weight gain? In this discussion, Dr. Robert Whitfield explores how gut health, digestion, inflammation, hormone signaling, recovery, and personalized physiology all influence metabolic health. Learn why GLP-1 agonists may be only one part of a much larger conversation involving the digestive system, nervous system, body composition, and long-term wellness planning. Dr. Whitfield shares a clinically grounded perspective on preparation, individualized care, and why sustainable metabolic health requires more than quick fixes. Read the full article to better understand the relationship between GLP-1 therapies, gut function, recovery, and whole-body health.
